Simulated Passive Jogging & Jumping Devices & NO
Non-Invasive Determination of Nitric Oxide Release by Simulated Passive Jogging & Jumping Devices
2 other identifiers
interventional
22
1 country
1
Brief Summary
Movement is important for overall health. Lack of movement has been shown to be associated with numerous diseases. This study will assess the validity and usefulness of two innovative low risk, non-invasive wellness devices, the Gentle Jogger® and the Gentle Jumper that passively simulate the physical activities of jogging and jumping, respectively. The study will evaluate whether or not each of the devices in different body postures (seated, lying down, slight recumbent and slight head down) produces changes in blood pressure, and indices of dilatation of blood vessels, in a younger (25-59yr) and older (\> 60 yrs.) subject population. Volunteers will be paid for their participation in the study. A substudy of this larger study ( Effects of Gentle Jogger on blood pressure), will determine the effects of 30 min of gentle jogger in seated and supine posture compared to Sham
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2017
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2017
CompletedFirst Submitted
Initial submission to the registry
January 25, 2018
CompletedFirst Posted
Study publicly available on registry
February 8, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 23, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 23, 2020
CompletedJanuary 27, 2020
April 1, 2019
2.9 years
January 25, 2018
January 23, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
a/b ratio from Photoplethysmogragh
Determination of the change in a/b ratio from the non invasively acquired arterial pulse waveform
3 hr
Secondary Outcomes (1)
Blood Pressure Changes
3 hr
Study Arms (8)
YG ( 25-59yrs) -GJogger
EXPERIMENTALGentle Jogger applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
OG (Greater than 60 yrs)-GJogger
EXPERIMENTALGentle Jogger applied to each individual in (1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
YG ( 25-59yrs) -GJumper
EXPERIMENTALGentle Jumper applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
OG (Greater than 60 yrs)-Gjumper
EXPERIMENTALGentle Jumper applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
YG ( 25-59yrs) -GJogger Sham
SHAM COMPARATORA Sham Gentle Jogger is applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
OG (Greater than 60 yrs)- GJogger-Sham
SHAM COMPARATORA Sham Gentle Jogger is applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
YG ( 25-59yrs) -GJumper- Sham
SHAM COMPARATORA Sham Gentle Jumper is applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
OG (Greater than 60 yrs)-GJumper Sham
SHAM COMPARATORA Sham Gentle Jumper is applied to each individual in 1) supine, 2) semi-recumbent, 3) sitting, 4) Trendelenburg and 5) reverse Trendelenburg Each Subject serves as his/her own control.
Interventions
Passive Simulated Jogging device (Gentle Jogger)
Passive Simulated Jumping Device ( Gentle Jumper)
Eligibility Criteria
You may qualify if:
- Age greater than 25 yrs
- Able to provide Informed Consent
You may not qualify if:
- Age less than 25 yrs
- Not able to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CIC Miami
Miami, Florida, 33136, United States
Related Publications (2)
Adams JA, Lopez JR, Nadkarni V, Zolkipli-Cunningham Z, Ischiropoulos H, Sackner MA. The effects of a motorized passive simulated jogging device on descent of the arterial pulse waveform dicrotic notch: A single arm placebo-controlled cross-over trial. Physiol Rep. 2022 Aug;10(15):e15418. doi: 10.14814/phy2.15418.
PMID: 35924333DERIVEDSackner MA, Patel S, Adams JA. Changes of blood pressure following initiation of physical inactivity and after external addition of pulses to circulation. Eur J Appl Physiol. 2019 Jan;119(1):201-211. doi: 10.1007/s00421-018-4016-7. Epub 2018 Oct 22.
PMID: 30350153DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jose A Adams, M.D.
Sackner Wellness Products LLC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2018
First Posted
February 8, 2018
Study Start
March 1, 2017
Primary Completion
January 23, 2020
Study Completion
January 23, 2020
Last Updated
January 27, 2020
Record last verified: 2019-04